Back to News News From Around the System All CampusesUC Davis HealthUC San Diego HealthUCI HealthUCLA HealthUCR HealthUCSF Health Drug found to correct gene defect that causes immune-driven gut leakiness UCR Health — UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells UCLA receives $6.4 million to fund cannabis research UCLA Health — The seven grants from the California Bureau of Cannabis Control will support research on health, policy and labor issues. Pagination First Previous Page 631 Page 632 Page 633 Page 634 Current page 635 Health Media Contacts Find the best contact for health-related media inquiries. View All Media Contacts
Drug found to correct gene defect that causes immune-driven gut leakiness UCR Health — UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells
UCLA receives $6.4 million to fund cannabis research UCLA Health — The seven grants from the California Bureau of Cannabis Control will support research on health, policy and labor issues.
